Clarent Biopharma, Inc.
Clarent Biopharma, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder | Not yet recruiting | Phase 2 | 2026-07-16 | NCT07706530 | |
| CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery | Hip or Knee Replacement | Recruiting | Phase 2 | 2026-07-07 | NCT07687966 | |
| Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Phase 2 | 2026-06-30 | NCT07204639 |